Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

4 курс / Акушерство и гинекология / Кузнецов_В_П_Тактика_ведения_беременных_с_преэклампсией,_осложненной

.pdf
Скачиваний:
0
Добавлен:
23.03.2024
Размер:
1.95 Mб
Скачать

221

199.Sherlock S., Dooley J. Diseases of liver and biliary system, 10th edn. // Oxford: Blackwell Sci. Publication. – London. – 1997. – P. 217 – 238.

200.Sibai B. Pre-eclampsia / B. Sibai, G. Dekker, M. Kupfermic // Lancet.

-2005. - Vol. 365. - P.785 - 799.

201.Sibai B.M. Pregnancies complicated by HELLP-syndrome (hemolysis, elevated liver enzymes and low platelets): subsequent pregnancy outcome and long-term prognosis / B. M. Sibai, M. K. Ramadan, R. S. Chari et.al. // Am. J. Obstet. Gynecol. - 1995. – Jan. - 172 (1). – P. 125 – 129.

202.Sommermeyer K. Differences in chemical structures between waxy maizeand potato starch-based hydroxyethyl starch volume therapeutics / K. Sommermeyer, F. Cech, R. Schossow // Transfusion Alternatives in Transfusion Medicine. - 2007. - 9(3). - P. 127 – 133.

203.Smith J., Mousa H.A. Peripartum hysterectomy for primary postpartum hemorrhage: incidence and maternal morbidity // J Obsted Gynecol. – 2007. –

27.– P. 44 – 47.

204.Spinato J. A. New therapies in the prevention of preeclampsia // Curr. Opin Obstet. Gynecol. - 2006. – N 18 (6) - P. 601604.

205.Steinborn A. Early detection of decreased soluble HLA-G levels in maternal circulation predicts the occurance of preeclampsia and intrauterine growth retardation during further course of pregnancy / A. Steinborn, T. Varkonyi, A. Scharf et al. // Am. J. Reprod. Immunol. - 2007. - Vol. 57. P. 277-

206.Strand R.T. Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration / R.T. Strand, F. Da Silva, E. Jangster // Acta Obstet Gynecol Scand. – 2005. – 84. – 3.

P. 260 – 265.

207.Sud S. Serial plasma fibronectin levels in preeclampsia / S. Sud, J. Gupta, L. Dhaliwal et al. // Intern. J. Obst. Gynec. - 1999. - Vol. 66. - Р. 123 - 128.

222

208.Sugawara J. Circulating endothelial progenitor cells during human pregnancy / J. Sugawara, M. Mitsui – Saitoi, T. Hoshiai et al. // J. Clin. Endocrinol. Metab. - 2005. –Vol. 90. – P. 1845-1848.

209.Takagi Y. Level of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction / Y. Takagi, T. Nikaido, T. Toki et al. // Virchows Arch. - 2004. – Vol. 444. - P. 49 -55.

210.Tannetta D.S. Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia / D. S. Tannetta, S. Muttukrishna, N. P. Groome et. al. // J. Clin. Endocrinol. Metab. - 2003. - V.88. - X912. - P. 5995 - 6001.

211.Takakuwa K., Arakawa M., Tamura M., Hataya I., Higashino M., Yasuda M., Tanaka K. HLA antigens in patients with severe preeclampsia. // J Perinat Med. – 1997. – 25. – 1. – P. 79-83.

212.The level of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. Acta Obstetrica et Gynecologica Scandinavica. 81(3), 2002. – P. 208-13.

213.Tsu V.D., Free M.J. Using technology to reduce maternal mortality in low-resource settings challenges and opportunities // Am Med Women’s Ass. –

2002. – P. 149 - 153.

214.Tuffnell D. J. The management of severe pre-eclampsia/eclampsia / D. J. Tuffnell, A. H. Shennan, J. J. Waugh et al. // London (UK): Royal College of Obstetricians and Gynecologists. - 2006. - Р.11.

215.Vatten L. J., Skjaerven R. Is pre-eclampsia more than one disease? // BLOG Int. J. Obstet. Gynaecol. – 2004. – Vol. 111. - P. 298-302.

216.Verlohren S. et. al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. // Am J Obstet Gynecol. – 2012. – 206. – 1. – 58. – P. 1 – 8.

217.Watson M. A. Human glutathione transferase P1 polymorphysms: relationship to lung tissue enzyme avtivity and population frequency distribution

223

/ M. A. Watson, R. K. Steward, G. B. Smith // Carcinogenesis. -1998. – Vol. 9.

-P. 275-280.

218.Waterstone M. Postnatal morbidity / М. Waterstone, С. Wolfe, R. Hooper // BJOG. - 2003. – Р. 128 – 133.

219.Willa C. Fornetti. Reliability and validity of body composition measures in female athletes / C. Fornetti Willa, M. Pivarnik James, M. Foley Jeanne et al. // The American Physiological Society. – 1999. – Р. 1114-1122.

220.Wang Y., Walsh S. Antioxidant activities and in RNA expression of superoxide dismutase catalase in normal and preeclamptic placentas // J. Soc. Gynaecol. Invest. – 1996. - № 3. – Р. 179 – 184.

221.Yang, J. Endothelial dysfunction and injury of placental and umbilical vessels in pregnancy – induced hypertension is associated with tumor necrosis factor / J. Yang, W. Xu, Q. Xu // Chinese journal of obstetrics and gynecology.- 2000.-Vol.35, №5. – P. 279 – 281.